InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,574.00
(
-2.14%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.24%
)
Bitcoin
64,184.14
(
1.06%
)
Post# of 29232
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119439
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 19783

Wednesday, 10/16/2019 9:21:02 AM

Wednesday, October 16, 2019 9:21:02 AM

Post# of 29232
ABT 3Q19 sales by business segment: 
  
 Medical devices* 38% (+11% YoY in const currency) 
 Diagnostics      24% ( +7% YoY in const currency) 
 Nutrition        23% ( +3% YoY in const currency) 
 Drugs†           15% ( +8% YoY in const currency)
65% of overall sales were ex-US.

*Including diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up